The graft unveils its secrets: provocative therapeutic leads to protected vascularized allografts.
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA. cferran@caregroup.harvard.edu
Christiane
C
Ferran
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control*; D002450:Cell Communication; D019610:Cytoprotection; D004268:DNA-Binding Proteins; D006084:Graft Rejection / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D009131:Muscle, Smooth, Vascular / Q000166:cytology*; D009687:Nuclear Proteins; D011506:Proteins / Q000502:physiology*; D014184:Transplantation, Homologous; D000072598:Tumor Necrosis Factor alpha-Induced Protein 3
D004268:DNA-Binding Proteins; D047908:Intracellular Signaling Peptides and Proteins; D009687:Nuclear Proteins; D011506:Proteins; C076529:TNFAIP3 protein, human; D000072598:Tumor Necrosis Factor alpha-Induced Protein 3